This inventor holds 1 USPTO granted patent. Top assignee: Pierce Management LLC. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Hans E Junginer
Introduction
Hans E Junginer is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the area of transdermal drug delivery systems. His work focuses on improving the administration of medications to enhance patient outcomes.
Latest Patents
Hans E Junginer holds a patent for an "Apparatus and method for transdermal delivery of bupropion." This invention includes a method where a patient is administered parenterally a bupropion base in an effective amount to alleviate withdrawal symptoms and reduce cravings for nicotine. Additionally, the invention provides a means to alleviate depression in patients through a transdermal delivery system that incorporates a bupropion base mixed with an acceptable pharmaceutical carrier. He has 1 patent to his name.
Career Highlights
Throughout his career, Hans has demonstrated a commitment to advancing medical technology. His innovative approach to drug delivery systems has the potential to improve the quality of life for individuals dealing with nicotine addiction and depression. His work exemplifies the intersection of science and practical application in healthcare.
Collaborations
Hans E Junginer has collaborated with notable professionals in his field, including Kamal K Midha and Mark Hirsh. These collaborations have likely contributed to the development and refinement of his innovative ideas.
Conclusion
Hans E Junginer's contributions to the field of pharmaceuticals through his patent for transdermal delivery systems highlight his role as an influential inventor. His work continues to pave the way for advancements in medication administration, ultimately benefiting patients in need.